The Senate last night voted 92-2 to approve the conference report to the Comprehensive Addiction and Recovery Act (S. 524), legislation designed to help stem the epidemic of opioid abuse through education, prevention, treatment and rehabilitation. The bill incorporates several key AHA-endorsed measures, including the creation of a multi-agency task force with a hospital representative that will develop best practices for prescribing and pain management; more stringent pre-market review of new opioids by the Food and Drug Administration; increased access to opioid overdose reversal drugs and medication-assisted treatment; and expanded research and treatment for vulnerable populations. The House passed the conference report last week and President Obama is expected to sign it into law. AHA members today received a Special Bulletin with more on the legislation, as well as recent actions by the administration and AHA to combat the opioid abuse epidemic. 

Headline
David Stark, chief of government and external affairs and philanthropy officer at UnityPoint Health, shares how a major philanthropic investment is helping…
Headline
The AHA announced April 13 that Deborah Bowen, president and CEO of the American College of Healthcare Executives, along with four retiring state hospital…
Headline
The AHA April 13 provided comments to the Department of Health and Human Services on the U.S. Core Data for Interoperability Draft Version 7, a standardized…
Chairperson's File
Public
More than 1,000 leaders from hospitals and health systems across the country will gather in Washington, D.C., early next week at the 2026 AHA Annual…
Headline
The Centers for Medicare & Medicaid Services April 10 released a proposed rule that would establish electronic standards for drug prior authorizations.…
Headline
Health care and public health was the top sector targeted for cyberthreats in 2025, according to the FBI’s latest annual report on internet crimes. There were…